欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/7288/001
药品名称Clindamycin Noridem 150 mg/ml Injektions-/Infusionslösung
活性成分
    • clindamycin phosphate 150.0 mg/ml
剂型Solution for injection/infusion
上市许可持有人Noridem Enterprises Limited Evagorou and Makariou Mitsi Building 3 Office 115 CY-1065 Nicosia Cyprus
参考成员国 - 产品名称Germany (DE)
Clindamycin Noridem 150 mg/ml Injektions-/Infusionslösung
互认成员国 - 产品名称
    • Ireland (IE)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Hungary (HU)
    • Czechia (CZ)
      Clindamycin noridem
    • Romania (RO)
      Clindamycin Noridem 150 mg/ml
    • Slovakia (SK)
许可日期2023/04/13
最近更新日期2024/04/26
药物ATC编码
    • J01FF01 clindamycin
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase